Therefore, upregulating SLC25A26 and limiting methionine intake in cancer cells may be able to further affect cellular methionine metabolism, potentially enhancing apoptosis and enhancing the effect of chemotherapy drugs. The gene discussed is SLC25A26; the disease is cancer.